Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
Rosetta Genomics Announces Participation in Cantor Fitzgerald’s Inaugural “From Bench to Bedside” Healthcare Conference
Cantor Fitzgerald Starts Rosetta Genomics (ROSG) at Hold
Rosetta Genomics (ROSG) Enters $10M Ordinary Share Controlled Equity Offering
Unusual 11 Mid-Day Movers 9/9: ENCO, VVUS, CLZR, HITK, DPTR Higher; OPXA, LRN, ROSG, ELOS Lower
Cantor Fitzgerald Downgrades Rosetta Genomics (ROSG) to Hold; Higher Execution Risk